Davis Capital Management
EW icon

Davis Capital Management’s Edwards Lifesciences EW Stock Holding History

Davis Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.38K Sell
16
-1
-6% -$89 ﹤0.01% 462
2026
Q2 		$1.54K Buy
17
+12
+240% +$1K ﹤0.01% 427
2026
Q1 		$400 Hold
5
– – ﹤0.01% 457
2025
Q4 		$426 Hold
5
– – ﹤0.01% 432
2025
Q3 		$389 Buy
+5
New +$391 ﹤0.01% 439

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Seilern Investment Management
Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return
Ninety One North America
Ninety One North America New York $2.13B AUM 8.8% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

Davis Capital Management's EW Position: Q3 2026 in Review

Davis Capital Management reduced its Edwards Lifesciences (EW) stake by 5.9% in Q3 2026, selling an estimated $89 and leaving 16 shares worth $1.38K. The position accounts for ﹤0.01% of the portfolio, ranked #462.

Davis Capital Management first reported a position in EW in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.54K in Q2 2026. 402 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Davis Capital Management held 16 shares of Edwards Lifesciences worth $1.38K as of Q3 2026.
  • Davis Capital Management sold 1 Edwards Lifesciences share in Q3 2026, an estimated $89.
  • Edwards Lifesciences made up ﹤0.01% of Davis Capital Management's portfolio in Q3 2026, its #462 holding.
  • Davis Capital Management first reported a position in Edwards Lifesciences in Q3 2025 and has held it in 5 quarters since.
  • Davis Capital Management's Edwards Lifesciences position peaked at $1.54K in Q2 2026.
  • 402 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.